Viral vector-mediated overexpression of α-synuclein was first introduced as a potential approach to modelling Parkinson’s disease just a few years after the implication of α-synuclein in the pathogenesis of the disease as the major component of Lewy bodies [2]. The gene discussed is SNCA; the disease is Parkinson disease.